These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8229086)

  • 1. In vitro studies of axonally-regulated Schwann cell genes during Wallerian degeneration.
    Thomson CE; Griffiths IR; McCulloch MC; Kyriakides E; Barrie JA; Montague P
    J Neurocytol; 1993 Aug; 22(8):590-602. PubMed ID: 8229086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of fast axonal transport in vivo leads to alterations in Schwann cell gene expression.
    Wu W; Toma JG; Chan H; Smith R; Miller FD
    Dev Biol; 1994 Jun; 163(2):423-39. PubMed ID: 7515362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary demyelination induced by exposure to tellurium alters Schwann cell gene expression: a model for intracellular targeting of NGF receptor.
    Toews AD; Griffiths IR; Kyriakides E; Goodrum JF; Eckermann CE; Morell P; Thomson CE
    J Neurosci; 1992 Sep; 12(9):3676-87. PubMed ID: 1382124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of growth-associated protein-43 kD in Schwann cells is regulated by axon-Schwann cell interactions and cAMP.
    Scherer SS; Xu YT; Roling D; Wrabetz L; Feltri ML; Kamholz J
    J Neurosci Res; 1994 Aug; 38(5):575-89. PubMed ID: 7815473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microanatomy of axon/glial signaling during Wallerian degeneration.
    Guertin AD; Zhang DP; Mak KS; Alberta JA; Kim HA
    J Neurosci; 2005 Mar; 25(13):3478-87. PubMed ID: 15800203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers.
    Cheng C; Zochodne DW
    Neuroscience; 2002; 115(1):321-9. PubMed ID: 12401344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration.
    Lee HK; Seo IA; Suh DJ; Hong JI; Yoo YH; Park HT
    J Neurochem; 2009 Feb; 108(3):776-86. PubMed ID: 19187095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular activity of resident macrophages during Wallerian degeneration.
    Shen ZL; Lassner F; Bader A; Becker M; Walter GF; Berger A
    Microsurgery; 2000; 20(5):255-61. PubMed ID: 11015722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration.
    Fernandez-Valle C; Bunge RP; Bunge MB
    J Neurocytol; 1995 Sep; 24(9):667-79. PubMed ID: 7500122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme Oxygenase 1 in Schwann Cells Regulates Peripheral Nerve Degeneration Against Oxidative Stress.
    Kim M; Kim H; Kim D; Kim D; Huh Y; Park C; Chung HJ; Jung J; Jeong NY
    ASN Neuro; 2019; 11():1759091419838949. PubMed ID: 31046408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP inhibits Schwann cell dedifferentiation and proliferation in an ex vivo model of Wallerian degeneration.
    Shin YH; Lee SJ; Jung J
    Biochem Biophys Res Commun; 2013 Jan; 430(2):852-7. PubMed ID: 23194661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.
    Morgan L; Jessen KR; Mirsky R
    J Cell Biol; 1991 Feb; 112(3):457-67. PubMed ID: 1704008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Schwann Cell-Neuron Coculture System to Study Neuron-Glia Interaction During Axon Degeneration.
    Babetto E
    Methods Mol Biol; 2020; 2143():97-110. PubMed ID: 32524475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development.
    Scherer SS; Xu YT; Bannerman PG; Sherman DL; Brophy PJ
    Development; 1995 Dec; 121(12):4265-73. PubMed ID: 8575326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
    Mews M; Meyer M
    Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry study of human vestibular nerve schwannoma differentiation.
    Hung G; Colton J; Fisher L; Oppenheimer M; Faudoa R; Slattery W; Linthicum F
    Glia; 2002 Jun; 38(4):363-70. PubMed ID: 12007148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axon-Schwann cell interactions regulate the expression of fibroblast growth factor-5 (FGF-5).
    Scarlato M; Xu T; Bannerman P; Beesley J; Reddy UR; Rostami A; Scherer SS; Pleasure D
    J Neurosci Res; 2001 Oct; 66(1):16-22. PubMed ID: 11598998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration.
    Liu HM; Yang LH; Yang YJ
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):487-96. PubMed ID: 7602323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Schwann cell surface and truncated nerve growth factor receptors in vitro by axonal components.
    DiStefano PS; Chelsea DM
    Brain Res; 1990 Nov; 534(1-2):340-4. PubMed ID: 1963563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons.
    Cheepudomwit T; Güzelsu E; Zhou C; Griffin JW; Höke A
    Neurosci Lett; 2008 Jan; 430(3):230-5. PubMed ID: 18068300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.